Macrocyclic Inhibitors of ERK2 Kinase

ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTMacrocyclic Inhibitors of ERK2 KinaseGerard Rosse*View Author Information Structure Guided Chemistry, Dart Neuroscience LLC, 7473 Lusk Boulevard, San Diego, California 92121, United States Adjunct Associate Professor, Department of Pharmacology and Physiology, College of Medicine, Drexel University, New College Building, 245 North 15th Street, Philadelphia, Pennsylvania 19102, United States*E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2016, 7, 12, 1020–1021Publication Date (Web):November 17, 2016Publication History Received2 November 2016Published online17 November 2016Published inissue 8 December 2016https://pubs.acs.org/doi/10.1021/acsmedchemlett.6b00434https://doi.org/10.1021/acsmedchemlett.6b00434editorialACS PublicationsCopyright © 2016 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1094Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (314 KB) Get e-AlertscloseSUBJECTS:Assays,Cancer,Inhibition,Inhibitors,Peptides and proteins Get e-Alerts